Fig. 1

Trial design. PCa = prostate cancer, MDT = Metastasis-directed therapy, sLND = salvage lymph node dissection, SBRT = stereotactic body radiotherapy, ADT = androgen deprivation therapy, WPRT = whole pelvic radiotherapy, RT = radiotherapy